Total Payments
$5,392
2024 Payments
$592.19
Companies
53
Transactions
336
Medicare Patients
4,340
Medicare Billing
$959,018
Payment Breakdown by Category
Food & Beverage$5,311 (98.5%)
Education$80.39 (1.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,311 | 330 | 98.5% |
| Education | $80.39 | 6 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $894.31 | 59 | $0 (2024) |
| UCB, Inc. | $595.44 | 28 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $510.67 | 31 | $0 (2022) |
| Janssen Biotech, Inc. | $481.40 | 35 | $0 (2024) |
| ABBVIE INC. | $448.24 | 32 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $225.76 | 10 | $0 (2024) |
| Lilly USA, LLC | $187.21 | 13 | $0 (2020) |
| Genentech USA, Inc. | $180.11 | 15 | $0 (2018) |
| Actelion Pharmaceuticals US, Inc. | $163.99 | 13 | $0 (2020) |
| PFIZER INC. | $153.42 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $592.19 | 30 | Amgen Inc. ($173.13) |
| 2023 | $572.75 | 30 | Amgen Inc. ($178.93) |
| 2022 | $839.02 | 45 | UCB, Inc. ($185.99) |
| 2021 | $345.46 | 22 | Janssen Biotech, Inc. ($83.68) |
| 2020 | $677.61 | 44 | Janssen Biotech, Inc. ($110.43) |
| 2019 | $714.47 | 54 | Amgen Inc. ($111.65) |
| 2018 | $768.80 | 50 | AbbVie, Inc. ($204.30) |
| 2017 | $881.53 | 61 | AbbVie, Inc. ($199.13) |
All Payment Transactions
336 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $35.67 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: Immunology | ||||||
| 10/07/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Inflammation | ||||||
| 10/03/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Inflammation | ||||||
| 08/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Immunology | ||||||
| 08/12/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: IMMUNOLOGY | ||||||
| 07/29/2024 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $7.73 | General |
| Category: Inflammation | ||||||
| 07/18/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Bone Health | ||||||
| 06/24/2024 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Inflammation | ||||||
| 06/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Inflammation | ||||||
| 06/11/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $28.06 | General |
| Category: Immunology | ||||||
| 05/31/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: IMMUNOLOGY | ||||||
| 05/16/2024 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Inflammation | ||||||
| 05/15/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 05/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/06/2024 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Inflammation | ||||||
| 04/26/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Immunology | ||||||
| 04/10/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Inflammation | ||||||
| 03/05/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Immunology | ||||||
| 02/28/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/21/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/08/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: Inflammation and Autoimmunity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,917 | 16,159 | $1.4M | $488,417 |
| 2022 | 20 | 1,653 | 11,293 | $976,420 | $358,176 |
| 2021 | 3 | 345 | 821 | $157,852 | $61,035 |
| 2020 | 4 | 425 | 860 | $137,361 | $51,390 |
Total Patients
4,340
Total Services
29,133
Medicare Billing
$959,018
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 16 | 10,250 | $922,500 | $344,824 | 37.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 263 | 742 | $181,790 | $65,523 | 36.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 22 | 1,800 | $45,000 | $33,253 | 73.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 46 | 256 | $43,008 | $11,459 | 26.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 209 | 522 | $54,810 | $5,368 | 9.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 30 | 30 | $12,600 | $4,478 | 35.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 219 | 526 | $10,652 | $4,410 | 41.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 64 | $11,200 | $3,993 | 35.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 212 | 525 | $25,200 | $3,972 | 15.8% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 221 | 442 | $10,166 | $2,226 | 21.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 66 | 173 | $7,353 | $1,794 | 24.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,465 | $1,397 | 40.3% |
| 85652 | Red blood cell sedimentation rate, to detect inflammation, automated | Office | 2023 | 220 | 441 | $11,687 | $1,158 | 9.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 37 | 38 | $9,500 | $1,102 | 11.6% |
| 86200 | Measurement of antibody for rheumatoid arthritis assessment | Office | 2023 | 54 | 54 | $5,400 | $685.26 | 12.7% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2023 | 16 | 32 | $1,920 | $649.79 | 33.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 24 | 25 | $2,150 | $411.50 | 19.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $385.00 | $324.61 | 84.3% |
| 86803 | Hepatitis c antibody measurement | Office | 2023 | 24 | 24 | $1,392 | $321.54 | 23.1% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 37 | 50 | $1,050 | $285.33 | 27.2% |
| 82550 | Creatine kinase (cardiac enzyme) level, total | Office | 2023 | 34 | 38 | $1,102 | $242.44 | 22.0% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 24 | 25 | $1,313 | $221.00 | 16.8% |
| 84550 | Uric acid level, blood | Office | 2023 | 19 | 22 | $528.00 | $97.46 | 18.5% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 15 | 17 | $374.00 | $86.36 | 23.1% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 21 | 24 | $672.00 | $74.64 | 11.1% |
About Dr. Jonathan Thomas, MD
Dr. Jonathan Thomas, MD is a Rheumatology healthcare provider based in Texarkana, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1043210149.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Thomas, MD has received a total of $5,392 in payments from pharmaceutical and medical device companies, with $592.19 received in 2024. These payments were reported across 336 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($5,311).
As a Medicare-enrolled provider, Thomas has provided services to 4,340 Medicare beneficiaries, totaling 29,133 services with total Medicare billing of $959,018. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Other Specialties Rheumatology
- Location Texarkana, TX
- Active Since 07/29/2005
- Last Updated 02/09/2022
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1043210149
Products in Payments
- Cimzia (Drug) $559.77
- COSENTYX (Biological) $474.95
- Enbrel (Biological) $432.24
- Humira (Biological) $408.70
- STELARA (Biological) $202.78
- DUPIXENT (Biological) $197.22
- Rituxan (Biological) $180.11
- TALTZ (Drug) $157.28
- SIMPONI ARIA (Biological) $138.56
- EVENITY (Biological) $129.62
- OPSUMIT MACITENTAN (Drug) $115.16
- TAVNEOS (Drug) $97.71
- BENLYSTA (Biological) $88.14
- KEVZARA (Drug) $83.03
- TREMFYA (Drug) $79.17
- PADCEV (Biological) $76.17
- Otezla (Drug) $75.25
- JYNARQUE (Drug) $73.32
- SAPHNELO (Biological) $58.65
- INFLECTRA (Biological) $54.13
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.